Back

Thiazolidinediones decrease risk of atrial fibrillation compared to other antidiabetic treatment

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Clinic, electrocardiogram, laboratory findings cardioversion and drugs in atrial fibrillation Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Jannik Langtved Pallisgaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

25 More presentations in this session

Presentation thumbnail
Long-term follow up of patients with non-valvular atrial fibrillation who undergo electrical cardioversion, comparison of direct oral anticoagulants and vitamin-k antagonists.
Miss L. Carrillo-Aleman (Torrevieja, ES)
Presentation thumbnail
Acute complications of elective cardioversion
Doctor T. Hellman (Turku, FI)
Abstract Slides
Presentation thumbnail
Ten year follow-up results after elective electrical cardioversions in a cohort of 806 patients with atrial fibrillation (1997 to 2006)
Doctor J. De La Chica (Malaga, ES)
Presentation thumbnail
Tissue differences in the atria of lone and no-lone atrial fibrillation patients
Doctor M. Batlle Perales (Barcelona, ES)
Abstract
Presentation thumbnail
Perioperative allopurinol reduces atrial fibrillation following coronary artery bypass graft surgery
Doctor Z. Efendi (Cibinong, ID)

Access the full session

Session thumbnail
Poster session 2 - Clinic, electrocardiogram, laboratory findings cardioversion and drugs in atrial fibrillation

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources